Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications
The application of nanotechnology in nuclear medicine offers attractive therapeutic opportunities for the treatment of various diseases, including cancer. Indeed, nanoparticles-conjugated targeted alpha-particle therapy (TAT) would be ideal for localized cell killing due to high linear energy transf...
Main Authors: | Maydelid Trujillo-Nolasco, Enrique Morales-Avila, Pedro Cruz-Nova, Kattesh V. Katti, Blanca Ocampo-García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1123 |
Similar Items
-
Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators
by: Ján Kozempel, et al.
Published: (2018-03-01) -
A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
by: Robin M. de Kruijff, et al.
Published: (2015-06-01) -
A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy
by: Uwe Holzwarth, et al.
Published: (2018-05-01) -
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis
by: Mari I. Suominen, et al.
Published: (2019-08-01) -
Evaluation of Actinium-225 Labeled Minigastrin Analogue [<sup>225</sup>Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
by: Yun Qin, et al.
Published: (2020-11-01)